Neurocrine Biosciences, Inc. (0K6R.L)

USD 92.1

(-0.04%)

Inventory Summary of Neurocrine Biosciences, Inc.

  • Neurocrine Biosciences, Inc.'s latest annual inventory in 2023 was 38.3 Million USD , up 9.12% from previous year.
  • Neurocrine Biosciences, Inc.'s latest quarterly inventory in 2024 Q1 was 37.2 Million USD , down -2.87% from previous quarter.
  • Neurocrine Biosciences, Inc. reported annual inventory of 35.1 Million USD in 2022, up 15.08% from previous year.
  • Neurocrine Biosciences, Inc. reported annual inventory of 30.5 Million USD in 2021, up 8.93% from previous year.
  • Neurocrine Biosciences, Inc. reported quarterly inventory of 42.5 Million USD for 2024 Q2, up 14.25% from previous quarter.
  • Neurocrine Biosciences, Inc. reported quarterly inventory of 45.8 Million USD for 2024 Q3, up 7.76% from previous quarter.

Annual Inventory Chart of Neurocrine Biosciences, Inc. (2023 - 1996)

Created with Highcharts 11.1.0YearsInventory19961998200020022004200620082010201220142016201820202022-40000000 USD-20000000 USD0 USD20000000 USD40000000 USD60000000 USD

Historical Annual Inventory of Neurocrine Biosciences, Inc. (2023 - 1996)

Year Inventory Inventory Growth
2023 38.3 Million USD 9.12%
2022 35.1 Million USD 15.08%
2021 30.5 Million USD 8.93%
2020 28 Million USD 61.96%
2019 17.28 Million USD 59.13%
2018 10.86 Million USD 134.9%
2017 -31.12 Million USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 100.0%
2013 -23 Thousand USD 99.84%
2012 -14.08 Million USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%
1999 - USD 0.0%
1998 - USD 0.0%
1997 - USD 0.0%
1996 - USD 0.0%

Peer Inventory Comparison of Neurocrine Biosciences, Inc.

Name Inventory Inventory Difference
uniQure N.V. 12.02 Million USD -218.53%
Agios Pharmaceuticals, Inc. 19.07 Million USD -100.776%
Amicus Therapeutics, Inc. 59.69 Million USD 35.842%
Atara Biotherapeutics, Inc. 9.7 Million USD -294.601%
bluebird bio, Inc. 22.91 Million USD -67.11%
Cara Therapeutics, Inc. 2.82 Million USD -1257.675%
Imunon, Inc. - USD -Infinity%
Editas Medicine, Inc. - USD -Infinity%
IQVIA Holdings Inc. - USD -Infinity%
Mettler-Toledo International Inc. 385.86 Million USD 90.074%
Myriad Genetics, Inc. 20.1 Million USD -90.547%
Supernus Pharmaceuticals, Inc. 77.4 Million USD 50.522%
Verastem, Inc. - USD -Infinity%
Walgreens Boots Alliance, Inc. 8.32 Billion USD 99.54%
Waters Corporation 516.23 Million USD 92.581%
Thermo Fisher Scientific Inc. 5.08 Billion USD 99.247%
Biogen Inc. 2.52 Billion USD 98.485%
Nektar Therapeutics 16.1 Million USD -137.873%
Perrigo Company plc 1.14 Billion USD 96.643%
Dynavax Technologies Corporation 53.29 Million USD 28.129%
Illumina, Inc. 587 Million USD 93.475%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Iovance Biotherapeutics, Inc. 10.37 Million USD -269.263%
Heron Therapeutics, Inc. 42.11 Million USD 9.048%
Unity Biotechnology, Inc. - USD -Infinity%
BioMarin Pharmaceutical Inc. 1.1 Billion USD 96.541%
Sangamo Therapeutics, Inc. - USD -Infinity%
Evolus, Inc. 10.99 Million USD -248.245%
Adicet Bio, Inc. - USD -Infinity%
Aclaris Therapeutics, Inc. - USD -Infinity%
Regeneron Pharmaceuticals, Inc. 2.58 Billion USD 98.516%
Esperion Therapeutics, Inc. 65.62 Million USD 41.636%
FibroGen, Inc. 41.56 Million USD 7.855%
Agilent Technologies, Inc. 1.03 Billion USD 96.285%
OPKO Health, Inc. 65.69 Million USD 41.702%
Homology Medicines, Inc. - USD -Infinity%
Geron Corporation - USD -Infinity%
Alnylam Pharmaceuticals, Inc. 89.14 Million USD 57.037%
Exelixis, Inc. 17.32 Million USD -121.093%
Viking Therapeutics, Inc. - USD -Infinity%
Anavex Life Sciences Corp. - USD -Infinity%
Intellia Therapeutics, Inc. - USD -Infinity%
Zoetis Inc. 2.56 Billion USD 98.506%
Axsome Therapeutics, Inc. 15.13 Million USD -153.056%
Abeona Therapeutics Inc. -2.44 Million USD 1667.103%
Vertex Pharmaceuticals Incorporated 738.8 Million USD 94.816%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Ionis Pharmaceuticals, Inc. 28.42 Million USD -34.741%
Sarepta Therapeutics, Inc. 322.85 Million USD 88.137%
Corcept Therapeutics Incorporated 7.73 Million USD -395.472%
Halozyme Therapeutics, Inc. 127.6 Million USD 69.985%
Blueprint Medicines Corporation 21.22 Million USD -80.465%
Insmed Incorporated 83.24 Million USD 53.993%
TG Therapeutics, Inc. 39.82 Million USD 3.824%
Incyte Corporation 62.97 Million USD 39.179%
Emergent BioSolutions Inc. 328.9 Million USD 88.355%